SALIZZATO, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.158
EU - Europa 245
AS - Asia 228
AF - Africa 1
OC - Oceania 1
Totale 1.633
Nazione #
US - Stati Uniti d'America 1.157
CN - Cina 141
IT - Italia 127
SG - Singapore 57
SE - Svezia 42
FI - Finlandia 22
DE - Germania 15
FR - Francia 13
VN - Vietnam 11
IN - India 9
UA - Ucraina 7
GB - Regno Unito 6
KR - Corea 6
NL - Olanda 6
IE - Irlanda 4
BE - Belgio 2
HK - Hong Kong 2
AZ - Azerbaigian 1
EG - Egitto 1
ID - Indonesia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PL - Polonia 1
Totale 1.633
Città #
Fairfield 174
Woodbridge 127
Chandler 116
Ashburn 90
Ann Arbor 79
Seattle 79
Wilmington 76
Houston 64
Cambridge 62
Padova 52
Singapore 43
Boardman 31
Beijing 30
Des Moines 28
New York 16
Princeton 16
Santa Clara 16
Nanjing 15
Medford 14
Jacksonville 13
Cagliari 12
Helsinki 12
Dong Ket 11
Nanchang 8
San Diego 7
Shenyang 7
Falls Church 6
Jinan 6
Tianjin 6
Arezzo 5
Changsha 5
Milan 5
Verona 5
Dublin 4
Guangzhou 4
Los Angeles 4
Naples 4
Ningbo 4
Roxbury 4
Vicenza 4
Bupyeong-gu 3
Gazzo 3
Ogden 3
Redwood City 3
Albignasego 2
Argenteuil 2
Brussels 2
Campodarsego 2
Chengdu 2
Dallas 2
Haikou 2
Hangzhou 2
Hebei 2
Hefei 2
Icheon-si 2
Kharkiv 2
Munich 2
Norwalk 2
Paris 2
Pasiano 2
San Giovanni La Punta 2
Sherman Oaks 2
Taizhou 2
Tappahannock 2
Xian 2
Auburn Hills 1
Baku 1
Bari 1
Cairo 1
Cardiff 1
Cheonan 1
Chiswick 1
Chongqing 1
Christchurch 1
Corpus Christi 1
Florence 1
Frankfurt (Oder) 1
Frankfurt am Main 1
Fuzhou 1
Groningen 1
Hanover 1
Hong Kong 1
Jakarta 1
Kunming 1
Lanzhou 1
Las Vegas 1
Mariano Comense 1
Mestrino 1
Newark 1
Pune 1
Rome 1
Saarbrücken 1
Saltillo 1
San Francisco 1
San Paolo Solbrito 1
Sant'elena 1
Shanghai 1
Taiyuan 1
Venezia 1
Venice 1
Totale 1.353
Nome #
CK2 modulates adipocyte insulin-signaling and is up-regulated in human obesity 203
Protein kinase CK2 potentiates translation efficiency by phosphorylating eIF3j at Ser127. 161
A journey through the cytoskeleton with protein kinase CK2 151
Protein kinase CK2 is involved in adipose tissue insulin signaling and remodeling during obesity and weight loss 142
Protein kinase CK2 subunits exert specific and coordinated functions in skeletal muscle differentiation and fusogenic activity 141
Aberrant signalling by protein kinase CK2 in imatinib-resistant chronic myeloid leukaemia cells. Biochemical evidence and therapeutic perspectives 124
Protein kinase CK2: a new target to overcome imatinib-resistance in chronic myeloid leukemia cells 78
Deciphering the role of protein kinase CK2 in the maturation/stability of F508del-CFTR 69
null 68
null 66
J-SUBUNIT OF THE EUKARYOTIC INITIATION FACTOR 3 IS A NEW SUBSTRATE OF PROTEIN KINASE CK2 62
Protein kinase CK2: a new target to overcome imatinib-resistance in CML cells 55
HOW PROTEIN KINASE CK2 IS INVOLVED IN IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA CELLS? 53
Targeting protein kinase CK2 to overcome imatinib-resitance 45
INVOLVEMENT OF THE PROTEIN KINASE CK2 AND ITS INTERACTOME IN IMATINIB SENSITIVE AND RESISTANT CHRONIC MYELOID LEUKEMIA CELLS 44
The protein kinase ck2 associates with and phosphorylates the eukaryotic initiation factor 3 41
Modulation of protein kinases in the regulation of chaperone machinery leading F508-del-CFTR fate - The Proceedings of the 16th Italian Convention of Investigators in Cystic Fibrosis 40
Protein kinase CK2: a new target to overcome imatinib-resistance in chronic myeloid leukemia cells. 39
Circulating cytokines as predictors of response to immune checkpoint inhibitors (ICIs) in patients (pts) with melanoma (Mel) and non–small cell lung cancer (NSCLC) 37
Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients 24
null 8
Cytokine and soluble programmed death-ligand 1 levels in serum and plasma of cancer patients treated with immunotherapy: Preanalytical and analytical considerations 6
Totale 1.657
Categoria #
all - tutte 6.130
article - articoli 4.802
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.932


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020233 0 0 0 0 30 18 36 35 29 47 30 8
2020/2021259 16 11 19 32 4 11 5 14 27 69 31 20
2021/2022249 2 33 33 29 22 18 6 24 10 4 16 52
2022/2023229 29 29 0 36 24 48 4 7 23 3 14 12
2023/2024194 7 21 22 13 22 24 9 26 17 12 11 10
2024/2025159 10 32 24 42 51 0 0 0 0 0 0 0
Totale 1.657